Evidence Analysis

It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.

Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:

  • Does the technology improve health outcomes?
  • Are there other benefits associated with the technology?
  • What harms might be associated with the technology?
  • Have patient selection criteria been established for the technology?
  • For which patients might the technology provide a benefit?

Platelet-Rich Plasma for Wound Treatment in Diabetic Foot Ulcers

Focus of the Report: This health technology assessment focuses on the use of platelet-rich plasma (PRP) for treatment of diabetic foot ulcers (DFUs).

Technology Description: PRP is an autologous blood preparation with a higher-than-usual concentration of platelets, platelet-derived gro…

Durysta (Allergan) Implant for Treatment of Glaucoma

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Durysta implant for reducing intraocular pressure (IOP) in glaucoma patients.